Voss Capital, LLC Galmed Pharmaceuticals Ltd. Transaction History

Voss Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$3.06 - $4.17 $382,500 - $521,250	-125,000 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.46 - $5.69 $30,794 - $50,641	-8,900 Reduced 6.65%	125,000 $443,000
Q2 2020 Aug 13, 2020	SELL	$3.22 - $6.08 $82,283 - $155,368	-25,554 Reduced 16.03%	133,900 $640,000
Q1 2020 May 15, 2020	BUY	$3.3 - $6.84 $29,498 - $61,142	8,939 Added 5.94%	159,454 $319,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $6.75 $543,359 - $1.02 Million	150,515 New	150,515 $870,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.78M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Voss Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Voss Capital, LLC with notifications on news.